AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.

Dato-DXd NSQ NSCLC application withdrawn in EU

Tagrisso approved in EU based on LAURA trial

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AstraZeneca PLC (AZN LN)

Dato-DXd NSQ NSCLC application withdrawn in EU

Tagrisso approved in EU based on LAURA trial

Directorate Change

Imfinzi approved in US for limited-stage SCLC

AstraZeneca appoints Iskra Reic EVP International

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)